UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
February 2, 2015
Date of Report
|
AVERY DENNISON CORPORATION |
|
(Exact name of registrant as specified in its charter) |
|
Delaware |
|
1 -7685 |
|
95-1492269 |
|
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
|
of incorporation) |
|
File Number) |
|
Identification No.) |
|
|
207 Goode Avenue |
|
| |
|
|
Glendale, California |
|
91203 |
|
|
|
(Address of principal executive offices) |
|
(Zip Code) |
|
Registrant’s telephone number, including area code (626) 304-2000
|
|
|
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 2 - Financial Information
Item 2.02 Results of Operations and Financial Condition.
Avery Dennison Corporation’s (the “Company’s”) press release, dated February 2, 2015, regarding the Company’s preliminary, unaudited financial results for fourth quarter and full year 2014, and guidance for the 2015 fiscal year, is attached hereto as Exhibit 99.1 and is being furnished (not filed) with this Form 8-K.
The Company’s supplemental presentation materials, dated February 2, 2015, regarding the Company’s preliminary, unaudited financial review and analysis for fourth quarter and full year 2014, and guidance for the 2015 fiscal year, is attached hereto as Exhibit 99.2 and is being furnished (not filed) with this Form 8-K. The press release and presentation materials are also available on the Company’s website at www.investors.averydennison.com.
The Company will discuss its preliminary, unaudited financial results during a webcast and teleconference today, February 2, 2015, at 11:00 a.m. ET. To access the webcast and teleconference, please go to the Company’s website at www.investors.averydennison.com.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
99.1 |
Press release, dated February 2, 2015, regarding the Company’s preliminary, unaudited fourth quarter and full year 2014 financial results. |
|
|
|
|
99.2 |
Supplemental presentation materials, dated February 2, 2015, regarding the Company’s preliminary, unaudited financial review and analysis for fourth quarter and full year 2014. |
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
Certain statements contained in this report on Form 8-K and in Exhibits 99.1 and 99.2 are forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements and financial or other business targets are subject to certain risks and uncertainties. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but not limited to risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; worldwide and local economic conditions; fluctuations in currency exchange rates and other risks associated with foreign operations, including in emerging markets; the financial condition and inventory strategies of customers; changes in customer preferences; fluctuations in cost and availability of raw materials; the Company’s ability to generate sustained productivity improvement; the Company’s ability to achieve and sustain targeted cost reductions; impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; integration of acquisitions and completion of potential dispositions; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; the Company’s ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; fluctuations in pension, insurance, and employee benefit costs; impact of legal and regulatory proceedings, including with respect to environmental, health and safety; changes in governmental laws and regulations; protection and infringement of intellectual property; changes in political conditions; impact of epidemiological events on the economy and the company's customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.
The Company believes that the most significant risk factors that could affect its financial performance in the near-term include (1) the impacts of economic conditions on underlying demand for the Company's products and foreign currency fluctuations; (2) competitors' actions, including pricing, expansion in key markets, and product offerings; and (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume.
For a more detailed discussion of these and other factors, see Part I, Item 1A. “Risk Factors” and Part II, Item 7. “Management’s Discussion and Analysis of Results of Operations and Financial Condition” in the Company’s 2013 Form 10-K, filed on February 26, 2014 with the Securities and Exchange Commission, and subsequent quarterly reports on Form 10-Q. The forward-looking statements included in this Form 8-K are made only as of the date of this Form 8-K, and the Company undertakes no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
AVERY DENNISON CORPORATION | |
|
|
| |
|
Date: February 2, 2015 |
| |
|
By: |
/s/ Mitchell R. Butier | |
|
|
Name: |
Mitchell R. Butier |
|
|
Title: |
President, Chief Operating Officer and |
|
|
|
Chief Financial Officer |
EXHIBIT LIST
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press release, dated February 2, 2015, regarding the Company’s preliminary, unaudited fourth quarter and full year 2014 financial results. |
|
|
|
|
|
99.2 |
|
Supplemental presentation materials, dated February 2, 2015, regarding the Company’s preliminary, unaudited financial review and analysis for fourth quarter and full year 2014. |
Exhibit 99.1
For Immediate Release
AVERY DENNISON ANNOUNCES
FOURTH QUARTER AND FULL YEAR 2014 RESULTS
|
Ø 4Q14 Reported EPS (including discontinued operations) of $0.76
Ø Adjusted EPS (non-GAAP, continuing operations) of $0.90
Ø 4Q14 Net sales grew approximately 1 percent on reported and organic basis to $1.6 billion
Ø FY14 Reported EPS (including discontinued operations) of $2.60
Ø Adjusted EPS (non-GAAP, continuing operations) of $3.11
Ø FY14 Net sales grew approximately 3 percent on reported and organic basis to $6.3 billion
Ø Expect FY15 Reported EPS of $2.95 to $3.15
Ø Adjusted EPS (non-GAAP) of $3.20 to $3.40
|
GLENDALE, Calif., February 2, 2015 – Avery Dennison Corporation (NYSE:AVY) today announced preliminary, unaudited results for its fourth quarter and full year ended January 3, 2015. All non-GAAP financial measures referenced in this document are reconciled to GAAP in the attached tables. Unless otherwise indicated, the discussion of the company’s results is focused on its continuing operations, and comparisons are to the same period in the prior year. Results reflect classification of former Office and Consumer Products (OCP) and Designed and Engineered Solutions (DES) businesses as discontinued operations. The company completed the sale of these businesses on July 1, 2013.
“I’m happy to report another year of solid progress toward our long-term goals, and I want to thank our employees for their contributions to our ongoing success,” said Dean Scarborough, Avery Dennison chairman and CEO. “In 2014, we delivered 16 percent growth in adjusted earnings per share, significantly increased return on capital, and distributed over $480 million of cash to shareholders.
“Pressure-sensitive Materials delivered its third consecutive year of strong volume growth, while maintaining its profitability and high return on capital. We are taking further actions to improve PSM’s long-term competitive position as we continue to invest in growth.
“Retail Branding and Information Solutions faced top-line growth challenges this year, reflecting share loss in the value and contemporary segments of the market, offset by solid growth in RFID and the performance segment,” Scarborough added. “We are focusing our sales efforts to recapture share, while reducing fixed costs and aligning resources to better serve all segments of the market. We expect to see an improvement in our growth trajectory by mid-year and to resume our strong record for margin expansion, with no change to our 2018 goals for the business.
“We expect to increase earnings per share in 2015, despite a significant headwind from currency translation,” said Scarborough. “We remain committed to achieving our long-term financial targets, growing through innovation and differentiated quality and service, with a continued focus on cost and capital discipline.”
For more details on the company’s results, see the summary table accompanying this news release, as well as the supplemental presentation materials, “Fourth Quarter and Full Year 2014 Financial Review and Analysis,” posted on the company’s website at www.investors.averydennison.com, and furnished to the SEC on Form 8-K.
Fourth Quarter 2014 Results by Segment
All references to sales reflect comparisons on an organic basis, which exclude the estimated impact of currency translation, product line exits, acquisitions and divestitures, and, where applicable, the extra week in the fiscal year. Adjusted operating margin refers to income before interest expense and taxes, excluding restructuring costs and other items, as a percentage of sales.
Pressure-sensitive Materials (PSM)
· PSM segment sales increased approximately 2 percent. Within the segment, Label and Packaging Materials increased low single digits. Combined sales of Graphics and Performance Tapes increased mid-single digits.
· Operating margin improved 60 basis points to 10.1 percent as the benefit from productivity initiatives and higher volume was partially offset by the net impact of raw material input costs and pricing along with higher restructuring costs. Adjusted operating margin improved 100 basis points.
Retail Branding and Information Solutions (RBIS)
· RBIS segment sales were down approximately 5 percent due to lower volume in Europe and North America.
· Operating margin declined 190 basis points to 5.5 percent as the impact of lower volume, a prior year gain on sale of assets, and other factors more than offset the benefit from productivity initiatives and lower employee costs. Adjusted operating margin declined 70 basis points.
Other
Share Repurchases
The company repurchased 7.4 million shares in 2014 at an aggregate cost of $356 million.
Income Taxes
The full year tax rate was 31.1 percent, below previous expectations of 33 percent, due primarily to benefits associated with tax planning in the fourth quarter. The tax rate in 2015 is expected to be in the low to mid-thirty percent range.
Cost Reduction Actions
In 2014, the company realized approximately $35 million in savings from restructuring, net of transition costs, and incurred restructuring costs of approximately $66 million, $55 million of which represents cash charges.
Outlook
In its supplemental presentation materials, “Fourth Quarter and Full Year 2014 Financial Review and Analysis,” the company provides a list of factors that it believes will contribute to its 2015 financial results. Based on the factors listed and other assumptions, the company expects 2015 earnings per share of $2.95 to $3.15. Excluding an estimated $0.25 per share for restructuring costs and other items, the company expects adjusted (non-GAAP) earnings per share of $3.20 to $3.40.
Note: Throughout this release and the supplemental presentation materials, amounts on a per share basis reflect fully diluted shares outstanding.
About Avery Dennison
Avery Dennison (NYSE:AVY) is a global leader in labeling and packaging materials and solutions. The company’s applications and technologies are an integral part of products used in every major market and industry. With operations in more than 50 countries and over 25,000 employees worldwide, Avery Dennison serves customers with insights and innovations that help make brands more inspiring and the world more intelligent. Headquartered in Glendale, California, the company reported sales from continuing operations of $6.3 billion in 2014. Learn more at www.averydennison.com.
# # #
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
Certain statements contained in this document are “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but not limited to risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; worldwide and local economic conditions; fluctuations in currency exchange rates and other risks associated with foreign operations, including in emerging markets; the financial condition and inventory strategies of customers; changes in customer preferences; fluctuations in cost and availability of raw materials; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; integration of acquisitions and completion of potential dispositions; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; fluctuations in pension, insurance, and employee benefit costs; impact of legal and regulatory proceedings, including with respect to environmental, health and safety; changes in governmental laws and regulations; protection and infringement of intellectual property; changes in political conditions; impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.
We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impacts of economic conditions on underlying demand for our products and foreign currency fluctuations; (2) competitors’ actions, including pricing, expansion in key markets, and product offerings; and (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume.
For a more detailed discussion of these and other factors, see “Risk Factors” and “Management’s Discussion and Analysis of Results of Operations and Financial Condition” in our 2013 Form 10-K, filed on February 26, 2014 with the Securities and Exchange Commission, and subsequent quarterly reports on Form 10-Q. The forward-looking statements included in this document are made only as of the date of this document, and we undertake no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law.
For more information and to listen to a live broadcast or an audio replay of the quarterly conference call with analysts, visit the Avery Dennison website at www.investors.averydennison.com
Contacts:
Media Relations:
David Frail (626) 304-2014
David.Frail@averydennison.com
Investor Relations:
Eric M. Leeds (626) 304-2029
investorcom@averydennison.com
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
|
Fourth Quarter Financial Summary - Preliminary, unaudited |
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
|
(in millions, except % and per share amounts) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
|
|
(14 weeks) |
|
(13 weeks) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
4Q |
|
4Q |
|
% Change vs. P/Y |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
2014 |
|
2013 |
|
Reported |
|
Organic (a) |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Net sales, by segment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Pressure-sensitive Materials |
|
$1,176.7 |
|
$1,149.1 |
|
2% |
|
2% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Retail Branding and Information Solutions |
|
405.6 |
|
417.4 |
|
-3% |
|
-5% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Vancive Medical Technologies |
|
22.5 |
|
17.4 |
|
29% |
|
32% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Total net sales |
|
$1,604.8 |
|
$1,583.9 |
|
1% |
|
1% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
As Reported (GAAP) |
|
Adjusted Non-GAAP (b) |
| ||||||||||||||||||
|
|
|
(14 weeks) |
|
(13 weeks) |
|
|
|
|
|
(14 weeks) |
|
(13 weeks) |
|
|
|
|
| ||||||
|
|
|
4Q |
|
4Q |
|
|
|
% of Sales |
|
4Q |
|
4Q |
|
|
|
% of Sales |
| ||||||
|
|
|
2014 |
|
2013 |
|
% Change |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
% Change |
|
2014 |
|
2013 |
| ||
|
Operating income (loss) before |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
interest and taxes, by segment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Pressure-sensitive Materials |
|
$119.3 |
|
$108.7 |
|
|
|
10.1% |
|
9.5% |
|
$124.6 |
|
$110.8 |
|
|
|
10.6% |
|
9.6% |
| ||
|
Retail Branding and Information Solutions |
|
22.4 |
|
31.0 |
|
|
|
5.5% |
|
7.4% |
|
27.6 |
|
31.5 |
|
|
|
6.8% |
|
7.5% |
| ||
|
Vancive Medical Technologies |
|
(4.5) |
|
(2.1) |
|
|
|
-20.0% |
|
-12.1% |
|
(0.4) |
|
(2.1) |
|
|
|
-1.8% |
|
-12.1% |
| ||
|
Corporate expense |
|
(22.0) |
|
(23.9) |
|
|
|
|
|
|
|
(22.0) |
|
(22.8) |
|
|
|
|
|
|
| ||
|
Total operating income before |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
interest and taxes / operating margin |
|
$115.2 |
|
$113.7 |
|
1% |
|
7.2% |
|
7.2% |
|
$129.8 |
|
$117.4 |
|
11% |
|
8.1% |
|
7.4% |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Interest expense |
|
$16.9 |
|
$16.0 |
|
|
|
|
|
|
|
$16.9 |
|
$16.0 |
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Income from continuing operations before taxes |
|
$98.3 |
|
$97.7 |
|
1% |
|
6.1% |
|
6.2% |
|
$112.9 |
|
$101.4 |
|
11% |
|
7.0% |
|
6.4% |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Provision for income taxes |
|
$28.2 |
|
$53.0 |
|
|
|
|
|
|
|
$29.1 |
|
$33.3 |
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Income from continuing operations |
|
$70.1 |
|
$44.7 |
|
57% |
|
4.4% |
|
2.8% |
|
$83.8 |
|
$68.1 |
|
23% |
|
5.2% |
|
4.3% |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Income (loss) from discontinued operations, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
net of tax |
|
$0.8 |
|
($2.0) |
|
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Net income |
|
$70.9 |
|
$42.7 |
|
66% |
|
4.4% |
|
2.7% |
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Net income (loss) per common share, assuming dilution: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Continuing operations |
|
$0.75 |
|
$0.45 |
|
67% |
|
|
|
|
|
$0.90 |
|
$0.69 |
|
30% |
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Discontinued operations |
|
$0.01 |
|
($0.02) |
|
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Total Company |
|
$0.76 |
|
$0.43 |
|
77% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
2013 |
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
4Q Free Cash Flow from Continuing Operations (c) |
|
|
|
|
|
|
|
$ |
121.9 |
|
$ |
225.1 |
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
(a) |
Percentage change in sales excluding the estimated impact of currency translation, product line exits, acquisitions, divestitures, and extra week in the fourth quarter of 2014. |
|
(b) |
Excludes restructuring costs and other items (see accompanying schedules A-2 to A-4 for reconciliation to GAAP financial measures). |
|
(c) |
Free cash flow refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments, plus discretionary contributions to pension plans and charitable contribution to Avery Dennison Foundation utilizing proceeds from divestitures. Free cash flow excludes uses of cash that do not directly or immediately support the underlying business, such as discretionary debt reductions, dividends, share repurchases, and certain effects of acquisitions and divestitures (e.g., cash flow from discontinued operations, taxes, and transaction costs). |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
|
Full Year Financial Summary - Preliminary, unaudited |
|
|
|
|
|
|
|
|
|
|
| ||||||||||
|
(in millions, except % and per share amounts) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
(53 weeks) |
|
(52 weeks) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FY |
|
FY |
|
% Change vs. P/Y |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
2014 |
|
2013 |
|
Reported |
|
Organic (a) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales, by segment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pressure-sensitive Materials |
|
$4,658.1 |
|
$4,455.0 |
|
5% |
|
5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail Branding and Information Solutions |
|
1,591.6 |
|
1,611.1 |
|
-1% |
|
-2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vancive Medical Technologies |
|
80.6 |
|
73.9 |
|
9% |
|
8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales |
|
$6,330.3 |
|
$6,140.0 |
|
3% |
|
3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As Reported (GAAP) |
|
Adjusted Non-GAAP (b) |
| ||||||||||||||||
|
|
|
(53 weeks) |
|
(52 weeks) |
|
|
|
|
|
(53 weeks) |
|
(52 weeks) |
|
|
|
|
| ||||
|
|
|
FY |
|
FY |
|
|
|
% of Sales |
|
FY |
|
FY |
|
|
|
% of Sales |
| ||||
|
|
|
2014 |
|
2013 |
|
% Change |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
% Change |
|
2014 |
|
2013 |
|
|
Operating income (loss) before |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
interest and taxes, by segment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pressure-sensitive Materials |
|
$434.4 |
|
$442.8 |
|
|
|
9.3% |
|
9.9% |
|
$476.0 |
|
$453.6 |
|
|
|
10.2% |
|
10.2% |
|
|
Retail Branding and Information Solutions |
|
87.9 |
|
81.7 |
|
|
|
5.5% |
|
5.1% |
|
109.9 |
|
101.7 |
|
|
|
6.9% |
|
6.3% |
|
|
Vancive Medical Technologies |
|
(11.7) |
|
(8.3) |
|
|
|
-14.5% |
|
-11.2% |
|
(7.5) |
|
(8.2) |
|
|
|
-9.3% |
|
-11.1% |
|
|
Corporate expense |
|
(82.9) |
|
(94.1) |
|
|
|
|
|
|
|
(82.5) |
|
(88.4) |
|
|
|
|
|
|
|
|
Total operating income before |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
interest and taxes / operating margin |
|
$427.7 |
|
$422.1 |
|
1% |
|
6.8% |
|
6.9% |
|
$495.9 |
|
$458.7 |
|
8% |
|
7.8% |
|
7.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
$63.3 |
|
$59.0 |
|
|
|
|
|
|
|
$63.3 |
|
$59.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before taxes |
|
$364.4 |
|
$363.1 |
|
0% |
|
5.8% |
|
5.9% |
|
$432.6 |
|
$399.7 |
|
8% |
|
6.8% |
|
6.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
$113.3 |
|
$118.8 |
|
|
|
|
|
|
|
$134.6 |
|
$131.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations |
|
$251.1 |
|
$244.3 |
|
3% |
|
4.0% |
|
4.0% |
|
$298.0 |
|
$268.6 |
|
11% |
|
4.7% |
|
4.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net of tax |
|
($2.2) |
|
($28.5) |
|
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Net income |
|
$248.9 |
|
$215.8 |
|
15% |
|
3.9% |
|
3.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common share, assuming dilution: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$2.62 |
|
$2.44 |
|
7% |
|
|
|
|
|
$3.11 |
|
$2.68 |
|
16% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations |
|
($0.02) |
|
($0.28) |
|
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
$2.60 |
|
$2.16 |
|
20% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
2013 |
|
|
|
|
|
|
|
|
Free Cash Flow from Continuing Operations (c) |
|
|
|
|
|
|
|
204.0 |
|
330.3 |
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
(a) |
Percentage change in sales excluding the estimated impact of currency translation, product line exits, acquisitions, divestitures, and extra week in the fourth quarter of 2014. |
|
(b) |
Excludes restructuring costs and other items (see accompanying schedules A-2 to A-5 for reconciliation to GAAP financial measures). |
|
(c) |
Free cash flow refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments, plus discretionary contributions to pension plans and charitable contribution to Avery Dennison Foundation utilizing proceeds from divestitures. Free cash flow excludes uses of cash that do not directly or immediately support the underlying business, such as discretionary debt reductions, dividends, share repurchases, and certain effects of acquisitions and divestitures (e.g., cash flow from discontinued operations, taxes, and transaction costs). |
AVERY DENNISON
PRELIMINARY CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share amounts)
|
|
|
| ||||||
|
|
|
(UNAUDITED) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
|
|
(14 weeks) |
|
(13 weeks) |
|
(53 weeks) |
|
(52 weeks) |
|
Net sales |
$ |
1,604.8 |
$ |
1,583.9 |
$ |
6,330.3 |
$ |
6,140.0 |
|
Cost of products sold |
|
1,189.7 |
|
1,167.6 |
|
4,679.1 |
|
4,502.3 |
|
Gross profit |
|
415.1 |
|
416.3 |
|
1,651.2 |
|
1,637.7 |
|
Marketing, general & administrative expense |
|
285.3 |
|
298.9 |
|
1,155.3 |
|
1,179.0 |
|
Interest expense |
|
16.9 |
|
16.0 |
|
63.3 |
|
59.0 |
|
Other expense, net (1) |
|
14.6 |
|
3.7 |
|
68.2 |
|
36.6 |
|
Income from continuing operations before taxes |
|
98.3 |
|
97.7 |
|
364.4 |
|
363.1 |
|
Provision for income taxes |
|
28.2 |
|
53.0 |
|
113.3 |
|
118.8 |
|
Income from continuing operations |
|
70.1 |
|
44.7 |
|
251.1 |
|
244.3 |
|
Income (loss) from discontinued operations, net of tax |
|
0.8 |
|
(2.0) |
|
(2.2) |
|
(28.5) |
|
Net income |
$ |
70.9 |
$ |
42.7 |
$ |
248.9 |
$ |
215.8 |
|
Per share amounts: |
|
|
|
|
|
|
|
|
|
Net income (loss) per common share, assuming dilution |
|
|
|
|
|
|
|
|
|
Continuing operations |
$ |
0.75 |
$ |
0.45 |
$ |
2.62 |
$ |
2.44 |
|
Discontinued operations |
|
0.01 |
|
(0.02) |
|
(0.02) |
|
(0.28) |
|
Net income per common share, assuming dilution |
$ |
0.76 |
$ |
0.43 |
$ |
2.60 |
$ |
2.16 |
|
Average common shares outstanding, assuming dilution |
|
93.0 |
|
98.5 |
|
95.7 |
|
100.1 |
(1) “Other expense, net” for the fourth quarter of 2014 includes severance and related costs of $6.7, asset impairment and lease cancellation charges of $6.9, and losses from curtailment and settlement of pension obligations of $1.
“Other expense, net” for the fourth quarter of 2013 includes severance and related costs of $6.3, asset impairment, lease and other contract cancellation charges of $1.4, and certain transaction costs of $1.1, partially offset by gains on sale of assets of $5.1.
“Other expense, net” fiscal year 2014 includes severance and related costs of $54.7, asset impairment and lease cancellation charges of $11.4, indefinite-lived intangible asset impairment charge of $3, and losses from curtailment and settlement of pension obligations of $1.6, partially offset by gains on sales of assets of $2.5.
“Other expense, net” for fiscal year 2013 includes severance and related costs of $27.2, asset impairment, lease and other contract cancellation charges of $13.1, charitable contribution to Avery Dennison Foundation of $10, certain transaction costs of $3.2, and legal settlement of $2.5, partially offset by gains on sale of assets of $17.8 and gain from curtailment of pension obligation of $1.6.
-more-
Reconciliation of Non-GAAP Financial Measures in Accordance with SEC Regulations G and S-K
We report financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that supplemental non-GAAP financial measures provide information that is useful to the assessment of our performance and operating trends, as well as liquidity.
Our non-GAAP financial measures exclude the impact of certain events, activities, or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, both positive and negative, of certain items (e.g., restructuring costs, asset impairments, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, losses from curtailment and settlement of pension obligations, gains or losses on sale of certain assets, and other items), we believe that we are providing meaningful supplemental information to facilitate an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.
We use the following non-GAAP financial measures in the accompanying news release and presentation:
Organic sales change refers to the increase or decrease in sales excluding the estimated impact of currency translation, product line exits, acquisitions and divestitures, and, where applicable, the extra week in the fiscal year.
Adjusted operating margin refers to income from continuing operations before interest expense and taxes, excluding restructuring costs and other items, as a percentage of sales.
Adjusted income from continuing operations refers to reported income from continuing operations adjusted for tax-effected restructuring costs and other items.
Adjusted EPS refers to reported income from continuing operations per common share, assuming dilution, adjusted for tax-effected restructuring costs and other items.
Free cash flow refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments, plus discretionary contributions to pension plans and charitable contribution to Avery Dennison Foundation utilizing proceeds from divestitures. Free cash flow excludes uses of cash that do not directly or immediately support the underlying business, such as discretionary debt reductions, dividends, share repurchases, and certain effects of acquisitions and divestitures (e.g., cash flow from discontinued operations, taxes, and transaction costs).
The reconciliations set forth below and in the accompanying presentation are provided in accordance with Regulations G and S-K and reconcile our non-GAAP financial measures with the most directly comparable GAAP financial measures.
-more-
AVERY DENNISON
PRELIMINARY RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(In millions, except % and per share amounts)
|
|
|
(UNAUDITED) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
|
|
(14 weeks) |
|
(13 weeks) |
|
(53 weeks) |
|
(52 weeks) |
|
Reconciliation of Operating Margins: |
|
|
|
|
|
|
|
|
|
Net sales |
$ |
1,604.8 |
$ |
1,583.9 |
$ |
6,330.3 |
$ |
6,140.0 |
|
Income from continuing operations before taxes |
$ |
98.3 |
$ |
97.7 |
$ |
364.4 |
$ |
363.1 |
|
Income from continuing operations before taxes as a percentage of sales |
|
6.1% |
|
6.2% |
|
5.8% |
|
5.9% |
|
Adjustment: |
|
|
|
|
|
|
|
|
|
Interest expense |
$ |
16.9 |
$ |
16.0 |
$ |
63.3 |
$ |
59.0 |
|
Operating income from continuing operations before interest expense and taxes |
$ |
115.2 |
$ |
113.7 |
$ |
427.7 |
$ |
422.1 |
|
Operating Margins |
|
7.2% |
|
7.2% |
|
6.8% |
|
6.9% |
|
Income from continuing operations before taxes |
$ |
98.3 |
$ |
97.7 |
$ |
364.4 |
$ |
363.1 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
Restructuring costs: |
|
|
|
|
|
|
|
|
|
Severance and related costs |
|
6.7 |
|
6.3 |
|
54.7 |
|
27.2 |
|
Asset impairment, lease and other contract cancellation charges |
|
6.9 |
|
1.4 |
|
11.4 |
|
13.1 |
|
Other items (1) |
|
1.0 |
|
(4.0) |
|
2.1 |
|
(3.7) |
|
Interest expense |
|
16.9 |
|
16.0 |
|
63.3 |
|
59.0 |
|
Adjusted operating income from continuing operations before interest expense and taxes (non-GAAP) |
$ |
129.8 |
$ |
117.4 |
$ |
495.9 |
$ |
458.7 |
|
Adjusted Operating Margins (non-GAAP) |
|
8.1% |
|
7.4% |
|
7.8% |
|
7.5% |
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP to Non-GAAP Income from Continuing Operations: |
|
|
|
|
|
|
|
|
|
As reported income from continuing operations |
$ |
70.1 |
$ |
44.7 |
$ |
251.1 |
$ |
244.3 |
|
Non-GAAP adjustments, net of tax: |
|
|
|
|
|
|
|
|
|
Restructuring costs and other items (2) |
|
13.7 |
|
23.4 |
|
46.9 |
|
24.3 |
|
Adjusted Non-GAAP Income from Continuing Operations |
$ |
83.8 |
$ |
68.1 |
$ |
298.0 |
$ |
268.6 |
-more-
(continued)
AVERY DENNISON
PRELIMINARY RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(In millions, except % and per share amounts)
|
|
|
(UNAUDITED) | ||||||
|
|
|
Three Months Ended |
|
Twelve Months Ended | ||||
|
|
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
Reconciliation of GAAP to Non-GAAP Income per Common Share from Continuing Operations: |
|
|
|
|
|
|
|
|
|
As reported income per common share from continuing operations, assuming dilution |
$ |
0.75 |
$ |
0.45 |
$ |
2.62 |
$ |
2.44 |
|
Non-GAAP adjustments per common share, net of tax: |
|
|
|
|
|
|
|
|
|
Restructuring costs and other items (2) |
|
0.15 |
|
0.24 |
|
0.49 |
|
0.24 |
|
Adjusted Non-GAAP Income per Common Share from Continuing Operations, assuming dilution |
$ |
0.90 |
$ |
0.69 |
$ |
3.11 |
$ |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
Average common shares outstanding, assuming dilution |
|
93.0 |
|
98.5 |
|
95.7 |
|
100.1 |
(1) Includes indefinite-lived intangible asset impairment charge, losses/gains from curtailment and settlement of pension obligations, charitable contribution to Avery Dennison Foundation, legal settlement, certain transaction costs, and gains on sales of assets.
(2) Reflects restructuring costs and other items, tax-effected at the full year tax rate.
|
|
|
(UNAUDITED) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(14 weeks) |
|
(13 weeks) |
|
(53 weeks) |
|
(52 weeks) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP to Non-GAAP Free Cash Flow: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
$ |
174.0 |
$ |
224.4 |
$ |
374.2 |
$ |
320.1 |
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment |
|
(47.1) |
|
(50.1) |
|
(147.9) |
|
(129.2) |
|
|
|
|
|
|
|
|
|
|
|
Purchases of software and other deferred charges |
|
(5.1) |
|
(17.6) |
|
(27.1) |
|
(52.2) |
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sales of property, plant and equipment |
|
0.2 |
|
7.9 |
|
4.3 |
|
38.7 |
|
|
|
|
|
|
|
|
|
|
|
Sales (purchases) of investments, net |
|
0.3 |
|
(0.5) |
|
0.3 |
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
Plus: charitable contribution to Avery Dennison Foundation utilizing proceeds from divestitures |
|
--- |
|
--- |
|
--- |
|
10.0 |
|
|
|
|
|
|
|
|
|
|
|
Plus: discretionary contributions to pension plans utilizing proceeds from divestitures |
|
--- |
|
50.1 |
|
--- |
|
50.1 |
|
|
|
|
|
|
|
|
|
|
|
Plus (minus): net divestiture-related payments and free cash (inflow) outflow from discontinued operations |
|
(0.4) |
|
10.9 |
|
0.2 |
|
92.7 |
|
|
|
|
|
|
|
|
|
|
|
Free Cash Flow - Continuing Operations |
$ |
121.9 |
$ |
225.1 |
$ |
204.0 |
$ |
330.3 |
-more-
AVERY DENNISON
PRELIMINARY SUPPLEMENTARY INFORMATION
(In millions, except %)
(UNAUDITED)
|
|
|
Fourth Quarter Ended |
| ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
NET SALES |
|
OPERATING INCOME |
|
OPERATING MARGINS |
| ||||||||||
|
|
|
2014 |
|
2013 |
|
2014 (1) |
|
2013 (2) |
|
2014 |
|
2013 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Pressure-sensitive Materials |
|
$ |
1,176.7 |
|
$ |
1,149.1 |
|
$ |
119.3 |
|
$ |
108.7 |
|
10.1% |
|
9.5% |
|
|
Retail Branding and Information Solutions |
|
405.6 |
|
417.4 |
|
22.4 |
|
31.0 |
|
5.5% |
|
7.4% |
| ||||
|
Vancive Medical Technologies |
|
22.5 |
|
17.4 |
|
(4.5) |
|
(2.1) |
|
(20.0%) |
|
(12.1%) |
| ||||
|
Corporate Expense |
|
N/A |
|
N/A |
|
(22.0) |
|
(23.9) |
|
N/A |
|
N/A |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
TOTAL FROM CONTINUING OPERATIONS |
|
$ |
1,604.8 |
|
$ |
1,583.9 |
|
$ |
115.2 |
|
$ |
113.7 |
|
7.2% |
|
7.2% |
|
(1) Operating income for the fourth quarter of 2014 includes severance and related costs of $6.7, asset impairment and lease cancellation charges of $6.9, and loss from curtailment and settlement of pension obligations of $1. Of the total $14.6, the Pressure-sensitive Materials segment recorded $5.3, the Retail Branding and Information Solutions segment recorded $5.2, and the Vancive Medical Technologies segment recorded $4.1.
(2) Operating income for the fourth quarter of 2013 includes severance and related costs of $6.3, asset impairment, lease and other contract cancellation charges of $1.4, and certain transaction costs of $1.1, partially offset by gains on sale of assets of $5.1. Of the total $3.7, the Pressure-sensitive Materials segment recorded $2.1, the Retail Branding and Information Solutions segment recorded $.5, and Corporate recorded $1.1.
RECONCILIATION OF GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION
|
|
|
Fourth Quarter Ended | ||||||||||
|
|
|
OPERATING INCOME |
|
|
OPERATING MARGINS | |||||||
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
2014 |
|
2013 |
|
|
2014 |
|
2013 |
| ||
|
Pressure-sensitive Materials |
|
|
|
|
|
|
|
|
|
| ||
|
Operating income and margins, as reported |
|
$ |
119.3 |
|
$ |
108.7 |
|
|
10.1% |
|
9.5% |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
| ||
|
Restructuring costs: |
|
|
|
|
|
|
|
|
|
| ||
|
Severance and related costs |
|
3.4 |
|
1.6 |
|
|
0.3% |
|
0.1% |
| ||
|
Asset impairment and lease cancellation charges |
|
1.1 |
|
0.5 |
|
|
0.1% |
|
--- |
| ||
|
Losses from curtailment and settlement of pension obligations |
|
0.8 |
|
--- |
|
|
0.1% |
|
--- |
| ||
|
Adjusted operating income and margins (non-GAAP) |
|
$ |
124.6 |
|
$ |
110.8 |
|
|
10.6% |
|
9.6% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Retail Branding and Information Solutions |
|
|
|
|
|
|
|
|
|
| ||
|
Operating income and margins, as reported |
|
$ |
22.4 |
|
$ |
31.0 |
|
|
5.5% |
|
7.4% |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
| ||
|
Restructuring costs: |
|
|
|
|
|
|
|
|
|
| ||
|
Severance and related costs |
|
3.4 |
|
4.7 |
|
|
0.8% |
|
1.1% |
| ||
|
Asset impairment, lease and other contract cancellation charges |
|
1.6 |
|
0.9 |
|
|
0.4% |
|
0.2% |
| ||
|
Loss from settlement of pension obligation |
|
0.2 |
|
--- |
|
|
0.1% |
|
--- |
| ||
|
Gains on sales of assets |
|
--- |
|
(5.1) |
|
|
--- |
|
(1.2%) |
| ||
|
Adjusted operating income and margins (non-GAAP) |
|
$ |
27.6 |
|
$ |
31.5 |
|
|
6.8% |
|
7.5% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Vancive Medical Technologies |
|
|
|
|
|
|
|
|
|
| ||
|
Operating loss and margins, as reported |
|
$ |
(4.5) |
|
$ |
(2.1) |
|
|
(20.0%) |
|
(12.1%) |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
| ||
|
Restructuring costs: |
|
|
|
|
|
|
|
|
|
| ||
|
Severance and related costs |
|
(0.1) |
|
--- |
|
|
(0.5%) |
|
--- |
| ||
|
Asset impairment charges |
|
4.2 |
|
--- |
|
|
18.7% |
|
--- |
| ||
|
Adjusted operating loss and margins (non-GAAP) |
|
$ |
(0.4) |
|
$ |
(2.1) |
|
|
(1.8%) |
|
(12.1%) |
|
-more-
AVERY DENNISON
PRELIMINARY SUPPLEMENTARY INFORMATION
(In millions, except %)
(UNAUDITED)
|
|
|
Twelve Months Year-to-Date |
| ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
NET SALES |
|
OPERATING INCOME |
|
OPERATING MARGINS |
| ||||||||||
|
|
|
2014 |
|
2013 |
|
2014 (1) |
|
2013 (2) |
|
2014 |
|
2013 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Pressure-sensitive Materials |
|
$ |
4,658.1 |
|
$ |
4,455.0 |
|
$ |
434.4 |
|
$ |
442.8 |
|
9.3% |
|
9.9% |
|
|
Retail Branding and Information Solutions |
|
1,591.6 |
|
1,611.1 |
|
87.9 |
|
81.7 |
|
5.5% |
|
5.1% |
| ||||
|
Vancive Medical Technologies |
|
80.6 |
|
73.9 |
|
(11.7) |
|
(8.3) |
|
(14.5%) |
|
(11.2%) |
| ||||
|
Corporate Expense |
|
N/A |
|
N/A |
|
(82.9) |
|
(94.1) |
|
N/A |
|
N/A |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
TOTAL FROM CONTINUING OPERATIONS |
|
$ |
6,330.3 |
|
$ |
6,140.0 |
|
$ |
427.7 |
|
$ |
422.1 |
|
6.8% |
|
6.9% |
|
(1) Operating income for fiscal year 2014 includes severance and related costs of $54.7, asset impairment and lease cancellation charges of $11.4, indefinite-lived intangible asset impairment charge of $3, and losses from curtailment and settlement of pension obligations of $1.6, partially offset by gains on sales of assets of $2.5. Of the total $68.2, the Pressure-sensitive Materials segment recorded $41.6, the Retail Branding and Information Solutions segment recorded $22, the Vancive Medical Technologies segment recorded $4.2, and Corporate recorded $.4.
(2) Operating income for fiscal year 2013 includes severance and related costs of $27.2, asset impairment, lease and other contract cancellation charges of $13.1, charitable contribution to Avery Dennison Foundation of $10, certain transaction costs of $3.2, and legal settlement of $2.5, partially offset by gains on sale of assets of $17.8, and gain from curtailment of pension obligation of $1.6. Of the total $36.6, the Pressure-sensitive Materials segment recorded $10.8, the Retail Branding and Information Solutions segment recorded $20, the Vancive Medical Technologies segment recorded $.1, and Corporate recorded $5.7.
RECONCILIATION OF GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION
|
|
|
Twelve Months Year-to-Date | ||||||||||
|
|
|
OPERATING INCOME |
|
|
OPERATING MARGINS | |||||||
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
2014 |
|
2013 |
|
|
2014 |
|
2013 |
| ||
|
Pressure-sensitive Materials |
|
|
|
|
|
|
|
|
|
| ||
|
Operating income and margins, as reported |
|
$ |
434.4 |
|
$ |
442.8 |
|
|
9.3% |
|
9.9% |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
| ||
|
Restructuring costs: |
|
|
|
|
|
|
|
|
|
| ||
|
Severance and related costs |
|
38.3 |
|
7.0 |
|
|
0.8% |
|
0.2% |
| ||
|
Asset impairment, lease and other contract cancellation charges |
|
1.9 |
|
3.8 |
|
|
0.1% |
|
0.1% |
| ||
|
Losses from curtailment and settlement of pension obligations |
|
1.4 |
|
--- |
|
|
--- |
|
--- |
| ||
|
Adjusted operating income and margins (non-GAAP) |
|
$ |
476.0 |
|
$ |
453.6 |
|
|
10.2% |
|
10.2% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Retail Branding and Information Solutions |
|
|
|
|
|
|
|
|
|
| ||
|
Operating income and margins, as reported |
|
$ |
87.9 |
|
$ |
81.7 |
|
|
5.5% |
|
5.1% |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
| ||
|
Restructuring costs: |
|
|
|
|
|
|
|
|
|
| ||
|
Severance and related costs |
|
16.0 |
|
19.9 |
|
|
1.0% |
|
1.2% |
| ||
|
Asset impairment, lease and other contract cancellation charges |
|
5.3 |
|
8.6 |
|
|
0.3% |
|
0.5% |
| ||
|
Indefinite-lived intangible asset impairment charge |
|
3.0 |
|
--- |
|
|
0.2% |
|
--- |
| ||
|
Gains on sales of assets |
|
(2.5) |
|
(6.9) |
|
|
(0.1%) |
|
(0.4%) |
| ||
|
Loss (gain) from settlement and curtailment of pension obligations |
|
0.2 |
|
(1.6) |
|
|
--- |
|
(0.1%) |
| ||
|
Adjusted operating income and margins (non-GAAP) |
|
$ |
109.9 |
|
$ |
101.7 |
|
|
6.9% |
|
6.3% |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Vancive Medical Technologies |
|
|
|
|
|
|
|
|
|
| ||
|
Operating loss and margins, as reported |
|
$ |
(11.7) |
|
$ |
(8.3) |
|
|
(14.5%) |
|
(11.2%) |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
| ||
|
Restructuring costs: |
|
|
|
|
|
|
|
|
|
| ||
|
Asset impairment charges |
|
4.2 |
|
0.1 |
|
|
5.2% |
|
0.1% |
| ||
|
Adjusted operating loss and margins (non-GAAP) |
|
$ |
(7.5) |
|
$ |
(8.2) |
|
|
(9.3%) |
|
(11.1%) |
|
-more-
AVERY DENNISON
PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions)
|
|
|
(UNAUDITED) |
| ||||
|
|
|
|
|
|
| ||
|
ASSETS |
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
| ||
|
|
|
|
|
|
| ||
|
Current assets: |
|
|
|
|
| ||
|
Cash and cash equivalents |
|
$ |
227.0 |
|
$ |
351.6 |
|
|
Trade accounts receivable, net |
|
958.1 |
|
1,016.5 |
| ||
|
Inventories, net |
|
491.8 |
|
494.1 |
| ||
|
Assets held for sale |
|
0.8 |
|
1.3 |
| ||
|
Other current assets |
|
246.4 |
|
228.3 |
| ||
|
|
|
|
|
|
| ||
|
Total current assets |
|
1,924.1 |
|
2,091.8 |
| ||
|
|
|
|
|
|
| ||
|
Property, plant and equipment, net |
|
875.3 |
|
922.5 |
| ||
|
Goodwill |
|
721.6 |
|
751.1 |
| ||
|
Other intangibles resulting from business acquisitions, net |
|
67.4 |
|
96.0 |
| ||
|
Non-current deferred income taxes |
|
365.4 |
|
263.4 |
| ||
|
Other assets |
|
463.6 |
|
485.8 |
| ||
|
|
|
|
|
|
| ||
|
|
|
$ |
4,417.4 |
|
$ |
4,610.6 |
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
| ||
|
|
|
|
|
|
| ||
|
Current liabilities: |
|
|
|
|
| ||
|
Short-term borrowings and current portion of long-term debt and capital leases |
|
$ |
204.3 |
|
$ |
76.9 |
|
|
Accounts payable |
|
797.8 |
|
889.5 |
| ||
|
Other current liabilities |
|
598.5 |
|
587.7 |
| ||
|
|
|
|
|
|
| ||
|
Total current liabilities |
|
1,600.6 |
|
1,554.1 |
| ||
|
|
|
|
|
|
| ||
|
Long-term debt and capital leases |
|
945.3 |
|
950.6 |
| ||
|
Other long-term liabilities |
|
805.0 |
|
613.7 |
| ||
|
Shareholders’ equity: |
|
|
|
|
| ||
|
Common stock |
|
124.1 |
|
124.1 |
| ||
|
Capital in excess of par value |
|
823.9 |
|
812.3 |
| ||
|
Retained earnings |
|
2,137.1 |
|
2,009.1 |
| ||
|
Treasury stock at cost |
|
(1,471.3 |
) |
(1,172.2 |
) | ||
|
Accumulated other comprehensive loss |
|
(547.3 |
) |
(281.1 |
) | ||
|
|
|
|
|
|
| ||
|
Total shareholders’ equity |
|
1,066.5 |
|
1,492.2 |
| ||
|
|
|
|
|
|
| ||
|
|
|
$ |
4,417.4 |
|
$ |
4,610.6 |
|
|
|
|
|
|
|
| ||
-more-
AVERY DENNISON
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
|
|
|
(UNAUDITED) |
| ||||
|
|
|
|
|
|
| ||
|
|
|
Twelve Months Ended |
| ||||
|
|
|
|
|
|
| ||
|
|
|
Jan. 03, 2015 |
|
Dec. 28, 2013 |
| ||
|
Operating Activities: |
|
|
|
|
| ||
|
Net income |
|
$ |
248.9 |
|
$ |
215.8 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
| ||
|
Depreciation |
|
135.5 |
|
135.6 |
| ||
|
Amortization |
|
66.1 |
|
69.0 |
| ||
|
Provision for doubtful accounts and sales returns |
|
20.7 |
|
16.3 |
| ||
|
Loss (gain) on sale of businesses |
|
3.4 |
|
(49.3 |
) | ||
|
Indefinite-lived intangible asset impairment charge |
|
3.0 |
|
- |
| ||
|
Net losses (gains) from asset impairments and sales/disposals of assets |
|
10.2 |
|
(5.8 |
) | ||
|
Stock-based compensation |
|
28.3 |
|
34.0 |
| ||
|
Other non-cash expense and loss |
|
44.2 |
|
49.3 |
| ||
|
Other non-cash income and gain |
|
--- |
|
(11.8 |
) | ||
|
Changes in assets and liabilities and other adjustments |
|
(186.1 |
) |
(133.0 |
) | ||
|
Net cash provided by operating activities |
|
374.2 |
|
320.1 |
| ||
|
Investing Activities: |
|
|
|
|
| ||
|
Purchases of property, plant and equipment |
|
(147.9 |
) |
(129.2 |
) | ||
|
Purchases of software and other deferred charges |
|
(27.1 |
) |
(52.2 |
) | ||
|
Proceeds from sales of property, plant and equipment |
|
4.3 |
|
38.7 |
| ||
|
Sales of investments, net |
|
0.3 |
|
0.1 |
| ||
|
Proceeds from sale of businesses, net of cash provided |
|
--- |
|
481.2 |
| ||
|
Other |
|
--- |
|
0.8 |
| ||
|
Net cash (used in) provided by investing activities |
|
(170.4 |
) |
339.4 |
| ||
|
Financing Activities: |
|
|
|
|
| ||
|
Net increase (decrease) in borrowings (maturities of 90 days or less) |
|
126.5 |
|
(435.3 |
) | ||
|
Additional borrowings (maturities longer than 90 days) |
|
--- |
|
250.0 |
| ||
|
Payments of debt (maturities longer than 90 days) |
|
(1.6 |
) |
(1.9 |
) | ||
|
Dividends paid |
|
(125.1 |
) |
(112.0 |
) | ||
|
Shares repurchases |
|
(355.5 |
) |
(283.5 |
) | ||
|
Proceeds from exercises of stock options, net |
|
34.2 |
|
44.8 |
| ||
|
Other |
|
(2.0 |
) |
(8.3 |
) | ||
|
Net cash used in financing activities |
|
(323.5 |
) |
(546.2 |
) | ||
|
Effect of foreign currency translation on cash balances |
|
(4.9 |
) |
2.9 |
| ||
|
(Decrease) increase in cash and cash equivalents |
|
(124.6 |
) |
116.2 |
| ||
|
Cash and cash equivalents, beginning of year |
|
351.6 |
|
235.4 |
| ||
|
Cash and cash equivalents, end of year |
|
$ |
227.0 |
|
$ |
351.6 |
|
####
Exhibit 99.2
|
|
Fourth Quarter and Full Year 2014 Financial Review and Analysis (preliminary, unaudited) Supplemental Presentation Materials Unless otherwise indicated, the discussion of the company’s results is focused on its continuing operations, and comparisons are to the same period in the prior year. Results reflect classification of Office and Consumer Products (OCP) and Designed and Engineered Solutions (DES) as discontinued operations. The company completed the sale of these businesses on July 1, 2013. February 2, 2015 |
|
|
Certain statements contained in this document are "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but not limited to risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; worldwide and local economic conditions; fluctuations in currency exchange rates and other risks associated with foreign operations, including in emerging markets; the financial condition and inventory strategies of customers; changes in customer preferences; fluctuations in cost and availability of raw materials; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; integration of acquisitions and completion of potential dispositions; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; fluctuations in pension, insurance, and employee benefit costs; impact of legal and regulatory proceedings, including with respect to environmental, health and safety; changes in governmental laws and regulations; protection and infringement of intellectual property; changes in political conditions; impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors. We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impacts of economic conditions on underlying demand for our products and foreign currency fluctuations; (2) competitors' actions, including pricing, expansion in key markets, and product offerings; and (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume. For a more detailed discussion of these and other factors, see “Risk Factors” and “Management’s Discussion and Analysis of Results of Operations and Financial Condition” in our 2013 Form 10-K, filed on February 26, 2014 with the Securities and Exchange Commission, and subsequent quarterly reports on Form 10-Q. The forward-looking statements included in this document are made only as of the date of this document, and we undertake no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law. |
|
|
Use of Non-GAAP Financial Measures This presentation contains certain non-GAAP financial measures as defined by SEC rules. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures, including limitations associated with these non-GAAP financial measures, are provided in the financial schedules accompanying the earnings news release for the quarter (see Attachments A-2 through A-5 to news release dated February 2, 2015). Our non-GAAP financial measures exclude the impact of certain events, activities, or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, both positive and negative, of certain items (e.g., restructuring costs, asset impairments, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, losses from curtailment and settlement of pension obligations, gains or losses on sale of certain assets, and other items), we believe that we are providing meaningful supplemental information to facilitate an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing. We use the following non-GAAP financial measures in this presentation: Organic sales change refers to the increase or decrease in sales excluding the estimated impact of currency translation, product line exits, acquisitions and divestitures, and, where applicable, the extra week in the fiscal year. Adjusted operating margin refers to income from continuing operations before interest expense and taxes, excluding restructuring costs and other items, as a percentage of sales. Adjusted income from continuing operations refers to reported income from continuing operations adjusted for tax-effected restructuring costs and other items. Adjusted EPS refers to reported income from continuing operations per common share, assuming dilution, adjusted for tax-effected restructuring costs and other items. Free cash flow refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments, plus discretionary contributions to pension plans and charitable contribution to Avery Dennison Foundation utilizing proceeds from divestitures. Free cash flow excludes uses of cash that do not directly or immediately support the underlying business, such as discretionary debt reductions, dividends, share repurchases, and certain effects of acquisitions and divestitures (e.g., cash flow from discontinued operations, taxes, and transaction costs). Adjusted EBITDA refers to earnings before interest expense, taxes, depreciation, and amortization, excluding restructuring costs and other items. Net debt to adjusted EBITDA refers to total debt less cash and cash equivalents, divided by adjusted EBITDA. Return on total capital refers to adjusted income from continuing operations excluding the expense and tax benefit of debt financing divided by the average of beginning and ending invested capital. This document has been furnished (not filed) on Form 8-K with the SEC and may be found on our website at www.investors.averydennison.com. |
|
|
Full Year Overview 2014 EPS growth in line with original guidance; continued progress towards long term targets Sales up approx. 3% on organic basis, driven by higher volume in PSM Operating margin, as reported, declined by 10 basis points Adjusted operating margin improved 30 basis points Reported EPS (including discontinued operations) of $2.60 Adjusted EPS (non-GAAP, continuing operations) of $3.11, up 16% Free cash flow from continuing operations of $204 mil. Below prior year due to higher working capital requirements (including year end timing of vendor payments and customer receipts) and currency fluctuation Expect ongoing free cash flow conversion of net income to be 100%+ Continued focus on cost and capital discipline Achieved approx. $35 million of restructuring savings Returned $481 million of cash to shareholders, including the repurchase of 7.4 million shares for $356 million |
|
|
Fourth Quarter Overview and 2015 Outlook 4Q 2014 EPS above expectations due to tax planning benefit Sales increased by approx. 1% on organic basis, below expectations due to decline in RBIS Operating margin, as reported, was unchanged as the benefit from productivity initiatives and higher volume roughly offset the net impact of raw material input costs and pricing, higher restructuring costs, and a prior year gain on sale of assets Adjusted operating margin improved 70 basis points Reported EPS (including discontinued operations) of $0.76 Adjusted EPS (non-GAAP, continuing operations) of $0.90, up 30% Free cash flow in the fourth quarter was $122 mil. 2015 Outlook Adjusted EPS of $3.20 to $3.40 on 3% to 4% organic sales growth Solid free cash flow and strong balance sheet Continued intent to return majority of cash to shareholders, while investing for future productivity and growth Fourth Quarter and Full Year 2014 Financial Review and Analysis February 2, 2015 |
|
|
4Q13 1Q14 2Q14 3Q14 4Q14 Organic Sales Change 6.6% 4.9% 4.0% 3.2% 0.5% Currency Translation 0.2% (1.2%) 0.1% 0.4% (3.7%) Extra week -- -- -- -- 4.5% Reported Sales Change* 6.8% 3.4% 4.1% 3.6% 1.3% Sales Trend Analysis *Totals may not sum due to rounding and other factors. |
|
|
Segment Sales and Margin Analysis 4Q14 Reported Organic Sales Growth: Pressure-sensitive Materials 2% 2% Retail Branding and Information Solutions (3%) (5%) Vancive Medical Technologies 29% 32% Continuing Operations 1% 1% Adjusted As Reported (Non-GAAP) 4Q14 4Q13 4Q14 4Q13 Operating Margin: Pressure-sensitive Materials 10.1% 9.5% 10.6% 9.6% Retail Branding and Information Solutions 5.5% 7.4% 6.8% 7.5% Vancive Medical Technologies (20.0%) (12.1%) (1.8%) (12.1%) Continuing Operations 7.2% 7.2% 8.1% 7.4% |
|
|
Fourth Quarter Segment Overview PRESSURE-SENSITIVE MATERIALS (PSM) Reported sales of $1.18 bil., up approx. 2% compared to prior year Sales up approx. 2% on organic basis Label and Packaging Materials sales up low single digits on organic basis Combined sales of Graphics and Performance Tapes up mid-single digits on organic basis Operating margin improved 60 basis points to 10.1% as the benefit from productivity initiatives and higher volume was partially offset by the net impact of raw material input costs and pricing along with higher restructuring costs Adjusted operating margin improved 100 basis points RETAIL BRANDING AND INFORMATION SOLUTIONS (RBIS) Reported sales of $406 mil., down approx. 3% due to lower volume in Europe and North America Sales down approx. 5% on organic basis Operating margin declined 190 basis points to 5.5% as the impact of lower volume, a prior year gain on sale of assets, and other factors more than offset the benefit from productivity initiatives and lower employee costs Adjusted operating margin declined 70 basis points |
|
|
Contributing Factors to 2015 Results Organic sales growth of 3% to 4% (excludes 2014 benefit from extra week of sales) Loss of extra week represents approx. 1% reduction to net sales Based on current rates, currency translation represents: ~6.5% reduction to net sales ~$35 mil. reduction to EBIT At current rates, reported net sales down 3.5% to 4.5% Expect incremental savings of ~$60 mil. from restructuring actions Tax rate in the low to mid-thirty percent range Average shares outstanding (assuming dilution) of ~91 mil. Capital expenditures (including IT) of ~$175 mil. and cash restructuring costs of ~$35 mil. Add Back: Estimated restructuring costs and other items ~$0.25 Adjusted EPS (non-GAAP) Reported EPS $2.95 - $3.15 2015 EPS Guidance $3.20 - $3.40 |
|
|
Strong progress against 2015 targets 3% – 5% Organic Sales Growth 10% – 15% Adjusted(2) Net Income Growth $300 mil.+ Annual Free Cash Flow 15% – 20%+ Adjusted(2) EPS Growth 1.7x to 2.0x Net Debt to Adjusted(2) EBITDA 2012 – 2015 TARGETS(1) ~4% 14% – 17% ~$300 mil. 19% – 21% < 2x 2012 – 2015 OUTLOOK(1) FROM CONTINUING OPERATIONS All percentages reflect four-year compound annual growth rates, with 2011 as the base period Excluding restructuring charges and other items |
|
|
Targeting Continued Strong Progress Through 2018 4% – 5% CAGR(1) Organic Sales Growth 9%–10% in 2018 (up ~ 2 pts vs 2013) Adjusted(2) Operating Margin 16%+ in 2018 (up 4+ pts vs 2013) Return on Total Capital (ROTC)(2) 12% – 15%+ CAGR(1) Adjusted(2) EPS Growth 1.7x to 2.0x Net Debt to adjusted(2) EBITDA 2014 – 2018 TARGETS 3% 7.8% 14% 16% 1.4x 2014 RESULTS Reflects five-year compound annual growth rates, with 2013 as the base period Excluding restructuring charges and other items |
|
|
Appendix: Reconciliation of Non-GAAP Financial Measures (Organic sales change) 3-Yr Avery Dennison 2011 2012 2013 2014 CAGR Net sales $5,844.9 $5,863.5 $6,140.0 $6,330.3 Organic sales change 3.8% 4.8% 3.1% 3.9% Foreign currency translation -3.4% 0.1% -1.1% Extra week impact 1.2% Reported sales change* 0.3% 4.7% 3.1% Pressure-sensitive Materials 2011 2012 2013 2014 Net sales $4,261.0 $4,257.6 $4,455.0 $4,658.1 Organic sales change 4.1% 4.7% 4.7% 4.5% Foreign currency translation -4.2% 0.1% -1.4% Extra week impact 1.2% Reported sales change* -0.1% 4.6% 4.6% Retail Branding & Information Solutions 2011 2012 2013 2014 Net sales $1,510.1 $1,535.0 $1,611.1 $1,591.6 Organic sales change 3.1% 4.9% -1.6% 2.1% Foreign currency translation -1.5% 0.0% -0.6% Extra week impact 1.1% Reported sales change* 1.6% 5.0% -1.2% Vancive Medical Technologies 2011 2012 2013 2014 Net sales $73.8 $70.9 $73.9 $80.6 Organic sales change 2.9% 7.6% 8.4% 6.3% Foreign currency translation -3.9% 1.4% 0.4% Product Line Exit -2.9% -4.8% Extra week impact 0.3% Reported sales change* -3.9% 4.2% 9.1% *Totals may not sum due to rounding and other factors. ($ in millions) |
|
|
Appendix: Reconciliation of Non-GAAP Financial Measures (EBIT/EBITDA Margins by Segment: Full Year 2014) Retail Pressure- Branding & Vancive sensitive Information Medical ($ in millions) Materials Solutions Technologies Net sales $4,658.1 $1,591.6 $80.6 Earnings before interest and taxes ("EBIT"), as reported $434.4 $87.9 ($11.7) EBIT margin, as reported 9.3% 5.5% -14.5% Non-GAAP Adjustments: Restructuring costs: Severance and related costs $38.3 $16.0 --- Asset impairment and lease cancellation charges $1.9 $5.3 $4.2 Other items $1.4 $0.7 --- Adjusted EBIT (non-GAAP) $476.0 $109.9 ($7.5) Adjusted EBIT margin (non-GAAP) 10.2% 6.9% -9.3% Depreciation and amortization* $116.1 $81.4 $4.2 Adjusted earnings before interest, taxes, depreciation & amortization ("EBITDA") $592.1 $191.3 ($3.3) Adjusted EBITDA margin 12.7% 12.0% -4.1% * Reflects total company depreciation and amortization expense, including indirect depreciation and amortization (primarily software) allocated to the segments on a percentage of sales basis |
|
|
Appendix: Reconciliation of Non-GAAP Financial Measures (Net Income and EPS) 3-Yr 2014 ($ in millions) 2011 2012 2013 2014 CAGR Growth As reported net income from continuing operations $141.7 $157.6 $244.3 $251.1 2.8% Non-GAAP adjustments, net of tax: Restructuring costs and other items $28.9 $45.0 $24.3 $46.9 Adjusted non-GAAP net income from continuing operations $170.6 $202.6 $268.6 $298.0 20.4% 10.9% 3-Yr 2014 2011 2012 2013 2014 CAGR Growth As reported net income per common share from continuing operations, assuming dilution $1.33 $1.52 $2.44 $2.62 7.4% Non-GAAP adjustments per common share, net of tax: Restructuring costs and other items $0.27 $0.44 $0.24 $0.49 Adjusted non-GAAP net income per common share from continuing operations, assuming dilution $1.60 $1.96 $2.68 $3.11 24.8% 16.0% EPS Net Income |
|
|
Appendix: Reconciliation of Non-GAAP Financial Measures (Net Debt to Adjusted EBITDA) 4-pt ($ in millions) 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 Avg. Net sales $1,498.9 $1,552.3 $1,504.9 $1,583.9 $1,550.1 $1,615.8 $1,559.6 $1,604.8 Earnings before interest and taxes ("EBIT"), as reported $93.3 $124.3 $90.8 $113.7 $103.2 $92.7 $116.6 $115.2 Non-GAAP Adjustments: Restructuring costs: Severance and related costs $6.8 $5.4 $8.7 $6.3 $7.0 $35.9 $5.1 $6.7 Asset impairment, lease and other contract cancellation charges $1.3 $2.4 $8.0 $1.4 $0.3 $2.6 $1.6 $6.9 Other items ($0.6) ($8.1) $9.0 ($4.0) --- --- $1.1 $1.0 Adjusted EBIT (non-GAAP) $100.8 $124.0 $116.5 $117.4 $110.5 $131.2 $124.4 $129.8 Depreciation $35.0 $34.5 $35.4 $30.7 $33.6 $32.4 $33.0 $36.5 Amortization $16.5 $17.3 $17.0 $18.2 $16.4 $17.0 $16.1 $16.6 Adjusted earnings before interest, taxes, depreciation & amortization ("EBITDA") $152.3 $175.8 $168.9 $166.3 $160.5 $180.6 $173.5 $182.9 Total Debt $1,357.4 $1,389.6 $1,065.7 $1,027.5 $1,118.3 $1,172.7 $1,112.2 $1,149.6 Less: Cash and cash equivalents $207.7 $211.6 $309.6 $351.6 $205.1 $221.9 $195.6 $227.0 Net Debt $1,149.7 $1,178.0 $756.1 $675.9 $913.2 $950.8 $916.6 $922.6 Net Debt to Adjusted LTM* EBITDA ( Non-GAAP) 1.4 1.4 1.3 1.3 1.4 *LTM = Last twelve months |
|
|
Appendix: Reconciliation of Non-GAAP Financial Measures (Return on Total Capital (ROTC)) ($ in millions) Avery Dennison 2012 2013 2014 As reported net income from continuing operations $244.3 $251.1 Non-GAAP adjustments, net of tax: Restructuring costs and other items $24.3 $46.9 Adjusted non-GAAP net income from continuing operations $268.6 $298.0 Interest Expense, net of tax benefit $39.6 $43.6 Effective Tax Rate 32.8% 31.1% Adjusted non-GAAP net operating profit after taxes from continuing operations $308.2 $341.6 Total Debt $1,222.4 $1,027.5 $1,149.6 Shareholders' Equity $1,580.9 $1,492.2 $1,066.5 Return on Total Capital (ROTC) 11.6% 14.4% |
|
|
© 2011 Avery Dennison Corporation. All rights reserved. Avery Dennison and all other Avery brands, product names and codes are trademarks of Avery Dennison Corporation. All other brands and product names are trademarks of their respective owners. Fortune 500 is a trademark of Time, Inc. Personal and company names and other information on samples depicted are fictitious. Any resemblance to actual names and addresses is purely coincidental. |
